ABC News: Impact of pandemic cancer screening pause
UC research examining the pandemic's negative impact on lung cancer screening featured
Millions of colonoscopies, mammograms, lung scans, Pap tests and other cancer screenings were suspended for several months last spring in the United States and elsewhere as COVID-19 became the priority in medical care.
Now researchers are studying the impact, looking to see how many cancers were missed and whether tumors found since then are more advanced.
Already, there are hints of trouble. University of Cincinnati researchers found that when CT scans to check for lung cancer resumed in June, 29% of patients had suspicious nodules versus 8% in prior years. This research was led by Robert Van Haren, MD, assistant professor of surgery at UC and a UC Health thoracic surgeon.
Read the full ABC News report.
Read more about the UC-led study.
Dr. Van Haren was also a guest on WVXU-FM's Cincinnati Edition program, discussing these findings.
Featured photo of Robert Van Haren, MD, looking at lung scan by Colleen Kelley.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Huff Post: The best workouts to do if you had COVID-19
April 16, 2021
UC Health orthopedic surgeon Brian Grawe, MD, advises on when it's safe to exercise if you catch COVID-19.
Yahoo: Researchers find a new treatment for rare muscular disease
April 16, 2021
University of Cincinnati researchers have found a newer, more effective treatment for the disease Pompe that could become the new standard of care for the rare condition.
A new treatment for rare muscular disease
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.